Effect of Linker Length and Composition on Heterobivalent Ligand‐Mediated Receptor Cross‐Talk between the A1 Adenosine and β2 Adrenergic Receptors |
| |
Authors: | Nicholas Barlow Prof. Stephen P. Baker Prof. Peter J. Scammells |
| |
Affiliation: | 1. Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville VIC 3052 (Australia);2. Department of Pharmacology & Therapeutics, University of Florida College of Medicine, Box 100267, Gainesville, FL 32610 (USA) |
| |
Abstract: | Heterobivalent ligands that possess pharmacophores designed to interact with both the A1 adenosine receptor (A1AR) and the β2 adrenergic receptor (β2AR) were prepared. More specifically, these ligands contain an adenosine moiety that is linked via its N6‐position to the amino group of the saligenin‐substituted ethanolamine moiety present in the well‐known β2AR agonist, salbutamol. The affinities of these ligands were determined at both receptors and found to vary with linker length and composition. With all compounds, affinity and functional potencies were found to have selectivity for the A1AR over the β2AR. In all cases, cAMP accumulation (a β2AR‐mediated response) was mainly observed when the A1AR was blocked or its function decreased by pertussis toxin or chronic agonist treatment. This suggests that heterobivalent compounds for receptors that mediate opposite responses might be useful for elucidating the mechanisms of receptor cross‐talk and how this interaction, in terms of responsiveness, may change under pathophysiological conditions. |
| |
Keywords: | A1 adenosine receptors β 2 adrenergic receptors combined pharmacophores heterobivalent ligands structure– activity relationships |
|
|